Publications

Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD

Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.

Acquired cold urticaria symptoms can be safely prevented by ebastine

Filename 57. Magerl et al.Acquired cold urt. Ebastine.Allergy 2007.pdf
Filesize 148.99 KB
Version o.057
Date added May 26, 2020
Downloaded 0 times
Category Original Work
Authors Magerl, M., Schmolke, J, Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.
Citation Magerl, M., Schmolke, J, Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.: Acquired cold urticaria symptoms can be safely prevented by Ebastine. Allergy 2007: 62; 1465-1468. IF: 5.01
Corresponding authors Maurer, M.
DocNum O.57
DocType PDF
Edition; Page 62; 1465-1468
IF 5.01
Publisher Allergy
ReleaseDate 2007

Background: Acquired cold urticaria (ACU) is a skin condition, in which exposure to cold results in wheals and itching and sometimes general systemic complications. It has a profound impact on patient quality of life. Secondgeneration antihistamines are recommended as the first-line treatment, but to date only a few have been scientifically tested for this condition.

Aim: To assess the safety and efficacy of ebastine in preventing ACU symptoms.

Methods: Twenty-two adult ACU patients participated in a double-blind crossover trial of 20 mg ebastine. The safety of ebastine was sensitively assessedwith a psychometric battery testing cognitive performance and  mood. After cold challenge, wheal and erythema were assessed by the investigator and the intensities of pruritus and burning were rated by the subject.

Results: Ebastine had no negative impact on any of the parameters of cognitive performance or mood. It dramatically reduced the number of patients who experienced wheals, pruritus, and burning after challenge.

Conclusion: Ebastine is safe and effective in preventing the symptoms of ACU.

 

(Last update: 12.2023)

Number of original publications in peer-reviewed journals:580
Number of reviews in peer-reviewed journals:210
Number of publications (original work and reviews) in peer-reviewed journals:790
Cumulative IF for original publications in peer-reviewed journals:4196.39
Cumulative IF for reviews in peer-reviewed journals:1409.32
Cumulative IF of publications (original work & reviews) in peer-reviewed journals:5605.71
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023)36836

Download-Information

To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.